PepGen (PEPG) launches stock offering to fund R&D and clinical trials for DM1 therapies.
PepGen launches public offering to fund clinical trials; shares up 34%
PepGen (PEPG) launches stock offering to fund R&D and clinical trials for DM1 therapies.